Automated Breast Ultrasound Systems Market size to exceed $5Bn by 2030

Automated Breast Ultrasound Systems (ABUS) Market size is expected to reach USD 5 billion by 2030, as per the latest research report announced by Global Market Insights Inc.
 

Several challenges associated with existing breast cancer screening techniques will complement the use of automated breast ultrasound systems in the healthcare sector. Mammography is one of the most commonly used technologies to detect breast cancers. However, the method is not as effective in examining individuals with high breast tissue density which can increase the likelihood of developing breast cancer by four to six times. It can still leave tumors undetected in dense-breasted women.
 

The lack of skilled medical personnel in the healthcare sector can restrain the ABUS industry growth. Even the most advanced ABUS relies on strong technical assistance during breast cancer screening tests for efficient handling of equipment and data interpretation. Increasing concerns among patients over incorrect interpretations due to inadequate training provided to healthcare professionals could hamper technology adoption.
 

Introduction of advanced automated breast ultrasound systems to improve cancer diagnosis

The automated breast ultrasound systems market from the automated breast ultrasound system (ABUS) segment was over USD 950 million in 2021. ABUS is a next-generation screening technology that allows the detection of minute masses and abnormal lesions in breast tissues with the help of high-resolution image detection. Technological advancements have helped industry players to develop novel screening systems that can significantly speed up the cancer diagnosis process. It helps save up valuable patient time and provides ease of detection.
 

Browse key industry insights spread across 160 pages with 124 market data tables & 14 figures & charts from the report, “Automated Breast Ultrasound Systems (ABUS) Market Analysis By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), End-use (Hospitals, Diagnostic Imaging Centers, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/automated-breast-ultrasound-market
 

High demand for focused healthcare to drive the use of ABUS in specialty centers

The ABUS market share from the specialty centers segment is anticipated to witness 14% CAGR between 2022-2030. The increasing need for early cancer diagnostics solutions will fuel the industry deployment. In recent years, the concept of single-specialty hospitals has gained considerable popularity. These facilities offer advanced services and resources to ensure efficient, convenient, and accessible healthcare therapies. The expansion of existing specialty centers for early detection and diagnosis of cancer will accelerate the segment progression.
 

New market entrants in North America to augment industry expansion

North America automated breast ultrasound systems market held 20% business share in 2021. New investments in the healthcare sector are encouraging market players to develop automated medical diagnosis systems. Countries like the U.S., and Canada are home to some of the notable ABUS companies that are making new product development and innovation.
 

Strategic alliances to boost automated breast ultrasound systems market size

Delphinus Medical Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Metritrack, Inc, QView Medical Inc., Siemens AG, SonoCine, Inc., Supersonic Imagine, Theraclion, CANON MEDICAL SYSTEMS CORPORATION, CapeRay Medical, Hitachi Ltd., and Seno Medical Instruments Inc., are some of the leading companies developing automated breast ultrasound systems. These companies are foraying into new partnerships and collaborations to gain a competitive advantage.